are constantly required to replenish differentiated blood cells characterized by high turnover or to respond to peripheral injuries such as bleeding, a portion of HSC must awake from their dormant state and re-activate proliferation and differentiation programs. 2 Thanks to their ability to correctly balance self-renewal and multi-potent differentiation the HSC pool size is maintained. However, the molecular pathways underlying this regulation are not completely understood, including the role of micro-RNA (miRNA). These are evolutionary conserved small noncoding RNA (ncRNA) that regulate mRNA stability and translation at the post-transcriptional level through nonperfect binding to target sequences. 3 To study the potential role for miRNA in HSC selfrenewal, we took advantage of the Pbx1 conditional knockout (Pbx1-cKO) mouse model. Pbx1 is a homeodomain transcription factor that positively regulates HSC quiescence. 4 Its absence in post-natal HSC causes an excessive proliferation that ultimately leads to their exhaustion, indicating a profound self-renewal defect, and a premature myeloid differentiation at the expense of lymphoid differentiation. 5 Therefore, the study of Pbx1-deficient HSC provides the opportunity to identify miRNA involved in the maintenance of HSC identity.
We employed Pbx1-cKO mice (and controls) to perform miRNA profiling of HSC and their immediate downstream progeny multi-potent progenitors (MPP) characterized by the absence of the Flk2 marker on their cell surface (Flk2-MPP, previously known as short-term HSC), representing one of the very first differentiation steps from HSC, with similar multi-potent differentiation capacity but reduced self-renewal. This approach allowed the identification of an HSC-specific miRNA, miR-127-3p. By modulating its activity through lentiviral vectors we demonstrate that miR-127 acts as a novel brake on differentiation that HSC employ to maintain their pool.
Methods

Mice
Tie2Cre
+ .Pbx1 -/f and Mx1Cre + .Pbx1 -/f mice have been described. 4, 6 Briefly, Tie2Cre 
miRNA profile and bioinformatic analysis
RNA was extracted with MirVana isolation kit (Ambion, ThermoFisher Scientific) from 1.4-2x10 3 HSC and 2-6x10 3 Flk2-MPPs (Table 1) f/f and Mx1Cre-Pbx1 f/f control mice (four experimental groups, 4-5 samples from individual mice/group). miRNA profiling was performed using the Megaplex TaqMan Assay system coupled with PreAmplification step (Rodent Pool A, Applied Biosystems, ThermoFisher Scientific). The expression level of 376 miRNA plus eight controls was obtained. Non-expressed miRNA (Ct level ≥35) were filtered out, whereas miRNA expressed in at least one of the four groups were further analyzed. Several normalization strategies were applied (quantile, median and endogenous normalization strategy) and quantile normalization was primarily chosen due to its smallest co-efficient of variation among replicates (cv=sdev/mean). 7 Differential expression (DE) analysis was performed by Statistical Analysis of Microarray 8 (SAM) (FDR with q-value <0.1).
Lentiviral constructs
Design and production of lentiviral vectors for stable ectopic miRNA-overexpression (OE vector) or functional downregulation (DR vector) were as previously described. 9, 10 Briefly, both vectors exploit the spleen focus forming virus (SFFV) promoter and couple miR-127-3p up-or downregulation with the expression of a cotranscribed fluorescence reporter protein (mOrange fluorescent protein, OFP, for OE vector and destabilized Green Fluorescence Protein, dGFP, for DR vector respectively). For the OE vector, a 274bp fragment containing murine pre-mir-127 was PCR-amplified and cloned into the XhoI and MluI sites inside the EF1a intron of lentiviral transfer plasmid #1394 (SFFV.EFintron.OFP; described by Lechman et al. 11 ). In the DR or 'sponge' vector, four tandem copies of an imperfectly complementary miR-127-3p target sequence were synthesized as described by Gentner et al. 10 and cloned into the 3' untranslated region (XbaI-XmaI sites) of the #1031scrT (LV.SFFV.dGFP) lentiviral backbone.
11 Third-generation lentiviral vector particles pseudotyped with VSV-G were generated as described.
12,13
Ethics
The study was approved by the Humanitas Clinical and Research Center -IRCCS Institutional Ethical Committee (prot. n. CE Humanitas, as per Ministerial Decree 127/14 of 8/2/2013).
Statistical analysis
Data are represented as mean±Standard Error (SE) when n>3. The significance of differences was determined by two-tailed Mann-Whitney unpaired test unless otherwise stated. P<0.05 was considered statistically significant (ns: not significant; * P<0.05; ** P<0.005; ***P<0.0005; ****P<0.0001). Statistical analyses were performed with GraphPad Prism (GraphPad Software).
Additional methods are presented in the Online Supplementary Methods. 14 and subjected to normalization, filtering and analysis ( Figure 1A) . A global analysis through unsupervised hierarchical clustering indicated a clear distinction between HSC and Flk2-MPP at the level of miRNA expression ( Figure 1B ), suggesting that miRNA regulate the first transition step in adult hematopoietic development. Within each group, Pbx1-deficient and control cells clustered separately, linking miRNA to selfrenewal impairment. Differential expression analysis indicated that 71 miRNA are differentially expressed (DE) during the physiological HSC-to-MPP transition ( Figure 1C , right, and Online Supplementary Table S1 ). A similar analysis on Pbx1-deficient HSC revealed 48 miRNA DE compared to control HSC ( Figure 1C, left) , half of which (n=23) are concordantly DE in the HSC-to-MPP list (Online Supplementary Table S2 ), in accordance with the hypothesis that miRNA are involved in HSC self-renewal. This result is similar to that obtained by analyzing mRNA, with Pbx1-deficient HSC exhibiting a transcriptional profile typical of their immediate downstream progeny.
Results
Pbx1
Importantly, the expression of most of the DE miRNA changed more than 2-fold. Of note, the most up-regulated miRNA in the normal HSC-to-MPP transition is miR-221 (Online Supplementary Figure S1 ). This represents a positive control of our analysis, since miR-221 has been predicted to be an important regulator of HSC maturation due to its ability to repress cKit. 15 We compared the lists of DE miRNA with those of DE transcripts obtained by microarray. 4 None of the DE miRNA between mutant HSC or Flk2 -MPP and corresponding controls are located within a transcript detected in the microarray, indicating that their different level of expression is not the result of the level of expression of a host gene.
Among the 23 over-lapping miRNA ( Figure 1C ), we applied stringent criteria to select a few candidates for subsequent studies. We considered only miRNA that: 1) were DE also by applying a different normalization method; 2) had a fold difference higher than five; 3) had anti-correlated predicted targets (PT) among previously described DE mRNA in Pbx1-deficient HSC; 4 4) were DE also with independent real-time PCR in wild-type (wt) samples. Only three miRNA candidates fulfilled each condition, all evolutionary conserved and all down-regulated (miR-127-3p, miR-411-5p, miR-34b-3p). Among these, the most DE both in Pbx1-deficient HSC and in the normal HSC-to-MPP transition is miR-127-3p (Online Supplementary Table S3 ). This miRNA was therefore chosen as a candidate HSC -self-renewal regulator.
miR-127-3p is an HSC-specific miRNA
As further proof that miR-127-3p downregulation correlates with loss of self-renewal, we confirmed its DE in phenotypically-defined HSC from a different previously described Pbx1-cKO mouse model (Tie2Cre + Pbx1 -/f ) 4, 5 ( Figure 2A ). We then prospectively isolated HSC and Flk2 -MPP from wt mice and compared the expression level of miR-127-3p to that of other miRNA previously associated to HSC, such as miR-99b, miR-125, let-7, miR-221 and miR-126. 11, [15] [16] [17] [18] [19] We found that miR-127-3p expression in HSC is not particularly high, being similar to that of other miRNA already reported to play a role in HSC biology ( Figure 2B ). We confirmed the recently reported downregulation of miR-99b in Flk2 -MPP 20 ( Figure 2C ). haematologica | 2019; 104(9) However, miR-127-3p showed the highest downregulation (>100-fold; miR-99b 3-fold) in the first step of hematopoietic differentiation, whereas the majority of the other miRNA are still expressed at the progenitor level and have only a modest reduction compared to HSC. We then used real-time PCR to investigate whether miR-127-3p is expressed in other hematopoietic cell subpopulations other than HSC within the BM in steadystate conditions. This issue was addressed by analyzing miR-127-3p expression from purified populations including different lineage committed progenitors, megakaryocyte and erythrocyte precursors, myeloid precursors and mature cells, and various lymphoid subsets (Table 1 and Figure 2D ), since expression in only one subgroup would not be detectable in pooled populations. Impressively, miR-127-3p was highly HSC-specific, being quickly down-regulated in the earliest step of hematopoietic differentiation, where loss of self-renewal occurs. Furthermore, we confirmed its expression in human HSC-enriched CD34 + cells from different sources ( Figure 2E ).
Inhibition of miR-127-3p function severely impairs HSC self-renewal
To investigate the role of miR-127-3p in HSC we transplanted lineage-negative (Lin-) cells from CD45.2 + wt mice into lethally irradiated syngeneic CD45.1 + recipients, after permanently inhibiting binding to its targets through a lentiviral sponge vector carrying the reporter protein dGFP, as previously described for other miRNA.
11 Since miR-127-3p targets in HSC are not known, we assessed effective downregulation of miR-127-3p activity on K562 cells. Upregulation of XBP-1 and BLIMP-1, two miR-127-3p targets, 21 indicated that the sponge vector worked as expected (Online Supplementary Figure S2 ).
Engraftment and multipotent reconstitution by Lintransduced cells was then monitored through periodic blood sampling of transplanted mice and at necropsy several weeks after transplant. The BM of some of the reconstituted mice was transplanted into secondary recipients to assess if, in the absence of miR-127-3p activity, HSC maintain their self-renewal ability ( Figure 3A) .
In primary recipients, survival curves were similar for all miR-127 controls HSC maintenance haematologica | 2019; 104(9) Figure S2B) . Similarly, the level of engraftment by sponge-transduced HSC (named 127DR for miR-127-3p functional downregulation), measured as the proportion of cells expressing the donor marker CD45.2 over time, was comparable to that of HSC transduced with a control vector carrying only dGFP (named EV for empty vector) ( Figure 3B ) or with untransduced cells (data not shown), with the exception of one mouse out of eleven. Sponge and control vectors express dGFP under the SFFV promoter, which is highly active in HSC, progenitors and myeloid cells, particularly monocytes. Due to its rapid turnover, dGFP is only detectable when expressed at very high levels. Therefore, even though the SFFV promoter has good and modest activity in B and T lymphocytes, respectively, the dGFP marker is hardly detectable in these lineages. 22 For this reason, we followed by FACS analysis dGFP expression in monocytes; this also served as an indirect measure of dGFP expression in HSC since, due to their high turnover, myeloid cells are continuously generated from HSC. Virtually all monocytes were GFP + , indicating a very efficient transduction of long-term reconstituting cells ( Figure 3C ). Importantly, GFP-negative or low B and T lymphocytes isolated from the spleen of transplanted mice contained vector sequences (Online Supplementary  Figure S2C ), indicating that they derived from transduced cells. We therefore safely monitored the presence of transduced cells in vivo through the donor marker CD45.2, since we could not rely on dGFP expression in all cells.
The kinetics of peripheral myeloid, B-and T-cell reconstitution from donor cells was similar in mice transplanted with 127DR-or EV-transduced HSC, as well as the proportion and number of the different cell types ( Figure 3D ), suggesting that suppression of miR-127-3p activity did not affect multi-lineage reconstitution. However, FACS analysis of the BM at necropsy revealed a significant depletion of donor-derived phenotypically defined HSC, which were GFP + ( Figure 3E ), without affecting their output of multi-potent progenitors and their lymphoid and myeloid differentiation potential, as confirmed on BM and spleen haematologica | 2019; 104(9) 
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( Figure 3F ). None of the transplanted animals displayed extramedullary hematopoiesis (data not shown), indicating that the observed HSC reduction was not due to abnormal egress from the BM. To evaluate whether there was a decrease in functional HSC independently of the immunophenotype used to define them, secondary transplants were performed by injecting a high dose of total BM cells from two individual primary recipients in lethally irradiated CD45.1 + secondary recipient mice. The number of transplanted donor BM cells was sufficient for allowing recovery after irradiation; however, most of the mice transplanted with cells derived from 127DR BM succumbed 4-6 weeks after transplant, soon after the challenge of the first blood withdrawal, suggesting a severe HSC defect ( Figure 4A ). Four weeks after transplant, donor myeloid chimerism was very high in all mice, without significant differences among the groups of mice transplanted with 127DR or EV transduced BM ( Figure 4B ), indicating that the early mortality of 127DR BM-transplanted mice was likely not due to homing or engraftment impairment. However, sponging miR127-3p severely compromised myeloid cell and platelet producmiR-127 controls HSC maintenance haematologica | 2019; 104 (9) 1749 Figure  S3A ). Several weeks after transplant, we analyzed the most primitive hematopoietic compartment within the BM of the two secondary sponge recipients that were still alive. This analysis revealed that HSC were either absent ( Figure 4E ) or belonged to the recipient (Online Supplementary Figure S3B) . LKS multipotent progenitors were donor-derived GFP + , indicating that HSC had originally engrafted at the time of the secondary transplant and were able to generate differentiated progeny throughout time; however, they failed to self-renew. Therefore, miR-127-3p activity is crucial for the maintenance of phenotypically and functionally defined HSC.
miR-127-3p prevents premature differentiation
To discern the biological mechanism at the basis of HSC loss, we tested if miR-127-3p is involved in regulating HSC quiescence, metabolic properties, survival, or prevention of premature differentiation, all necessary to preserve self-renewal. All these features were initially analyzed on Lin -cells isolated ex vivo from transplanted mice, as opposed to newly transduced cells, in order to avoid potential influences of cell culture.
The proportion of cycling and quiescent HSC was similar in 127DR-and EV-transduced BM ( Figure 5A ), as well as the proportion of apoptotic cells ( Figure 5B ), indicating that miR127-3p downregulation does not alter HSC cell cycle or apoptosis.
Since oxidative stress has been described to negatively affect HSC function, we measured reactive oxygen species (ROS) production in response to cytokine stimulation, as described. 23 ROS production induced upon short in vitro cytokine exposure was similar in HSC within Lin -cells isolated from 127DR or EV recipients ( Figure 5C ), suggesting that miR-127-3p downregulation does not lead to an increase in oxidative stress. However, after only one day of culture, a reduced expression level (measured by MFI) of the stem-cell associated cKit marker was observed in 127DR cells ( Figure 5D ), suggesting that miR-127-3p downregulation leads to accelerated differentiation. Lin -cells isolated from 127DR or EV recipients were also subjected to a standard colony assay ( Figure 5E ). 127DR stem and progenitor cells generated a significantly lower proportion of immature colonies compared to mature ones, in accordance with the hypothesis that they are more prone to differentiate. We confirmed this phenotype using freshly isolated HSC cultured in vitro. HSC were sorted from wt mice using the EPCR marker, 24, 25 transduced and analyzed at different time points. Single-cell colony assay performed early after transduction revealed that, despite the fact that the total number of colonies was comparable in the 127DR and EV groups, sponged cells generated fewer CFU-GEMM colonies, which originate from the most immature cells ( Figure 5F ). FACS analysis did not show any differences in the two groups when the conventional CD48, CD150 staining was performed (Online Supplementary Figure S4A) ; however, at day 6, the proportion of HSC expressing EPCR was reduced ( Figure  5G and Online Supplementary Figure S4B) . Moreover, a higher proportion of cells displayed early signs of differen- Figure 5H ). The proportion of cKit + within dGFP + cells was very high in both experimental groups at day 6. However, at day 9, it dropped significantly in cultures derived from sponged HSC, while this decrease was less dramatic in the EV group. Accordingly, cKit expression level was significantly lower at day 9 in the 127DR group ( Figure 5I) . Finally, the expression of genes with myeloid expression pattern (Gene Expression Commons 26 ) was higher in sponged cells from day 9 cultures compared to cells transduced with EV ( Figure 5J) .
Overall, these data suggest that a faster differentiation miR-127 controls HSC maintenance haematologica | 2019; 104(9) 1751 
Forced miR-127-3p expression does not affect hematopoietic stem cell maintenance
We next asked whether increased miR-127-3p levels affect HSC function in vivo. Lentiviral-mediated miR-127 overexpression was performed in wt CD45.2 + Lin -cells, followed by transplantation in CD45.1 + recipient mice (Online Supplementary Figure S5A) . miR-127-overexpression (127OE) vector carried the Orange Fluorescent Protein (OFP) as reporter gene and the corresponding empty vector (EV), carrying only the reporter protein, was used as control. We obtained very high transduction efficiency with both vectors (data not shown). Expression analysis through real-time PCR before and after transduction confirmed that the progeny of infected cells expressed miR-127-3p, reaching levels similar to those of miR-16, which is present in all hematopoietic cells (Online Supplementary Figure S5B) . Periodic PB analysis revealed that 127OE Lin -cells were able to engraft and undergo multi-lineage differentiation, similar to Lin -cells transduced with the EV (data not shown). However, several weeks after transplant, peripheral B-and T-cell counts were significantly lower in mice transplanted with miR-127 over-expressing cells, compared to mice transplanted with the EV (Figure 6A ). These differences were present also in BM ( Figure 6B ) and spleen (data not shown), and are consistent with the reported suppression of germinal center regulators by human miR-127, 21, 27 likely reflecting the lack of miR-127 downregulation from the MPP stage onward rather than upregulation in HSC. In mice transplanted with 127OE cells, the level of miR-127-3p expression in the spleen several weeks after transplantation was haematologica | 2019; 104(9) Figure S5C) , thus excluding effects due to supra-physiological expression. The observed lymphopenia was not accompanied by myeloproliferation or splenomegaly, as expected if 127OE were to lead to HSC expansion. Indeed, 127OE did not affect maintenance of stem and progenitor cells ( Figure  6C ). This is similar to what has been described for miR-99, which did not cause HSC defects when over-expressed, despite its function in regulating HSC self-renewal being revealed after downregulation. 20 To test whether miR-127OE HSC show an advantage when subjected to challenging conditions, transduced Lin -cells were transplanted in competition with un-transduced cells at different ratios, and the presence of OFP + donor cells was monitored over time on myeloid cells in the PB, as described for the sponge experiments, as well as in BM and spleen at necropsy (Online Supplementary Figure S5D) . 127OE OFP + cells did not expand in primary recipients ( Figure 6D and E). Donor-derived OFP + stem cells were functionally competent, since they engrafted, expanded and gave rise to multi-lineage progeny in secondary recipients ( Figure 6F and G), independently from the overexpression of miR-127. However, lower lymphoid reconstitution was detected in secondary recipients ( Figure 6G ).
Taken together, these results suggest that miR-127-3p maintains the HSC pool by limiting premature differentiation, and must be down-regulated upon HSC maturation to maintain correct homeostasis of the hematopoietic system.
Discussion
In this report we demonstrate that miR-127-3p is an important novel regulator of the balance between selfrenewal and differentiation in HSC.
The miR-127 gene is encoded in a large evolutionary conserved miRNA gene cluster located within an imprinted domain (14q32 in human, 12qF in mouse), 28 the Dlk1-Gtl2 locus. On the maternally imprinted allele, this locus encodes multiple long ncRNA, snoRNA and a mega-cluster of miRNA organized in two groups, among which the miR-127/miR-136 cluster composed of 7 miRNA genes. RNA-seq data showed that the entire locus, which is regulated by a common cis-element, is specifically transcribed in CD49b lo long-term HSC compared to all other BM progenitor and mature cells. 28 However, according to our profiling, of the miR-127/miR-136 cluster, only miR-127 and miR-434 are expressed as mature forms in adult HSC. Similarly, of all the other miRNA included in the Dlk1-Gtl2 locus beside the miR-127/miR-136 cluster, only miR-411 is expressed in HSC. Of note, three out of the four top miRNA in our HSC-to-MPP list are part of this locus (Online Supplementary Table S2 ), in line with previous data showing that ncRNA within the Dlk1-Gtl2 locus can be considered HSC markers. 28 The miR-127 gene is embedded in a CpG island; therefore, it is conceivable that the rapid downregulation in the earliest step of hematopoietic differentiation is due to epigenetic silencing. Indeed, the expression of miR-127 was experimentally induced in cancer cell lines by chromatin-modifying drugs, which did not affect expression of the other members of the miRNA gene cluster. 29 The entire locus has been inactivated in the maternallyderived allele. 30, 31 Due to embryonic lethality, the consequences on hematopoiesis were studied using fetal liver stem and progenitor cells. The phenotype observed presented features similar to what we observed in mice transplanted with 127DR Lin -cells, such as reduction of HSC despite normal progenitor and lineage cell counts, and defective long-term reconstitution capacity. 28 Altered PI3K-mTOR pathway affecting mitochondrial metabolism explained this phenotype, 28 although other molecular mechanisms cannot be excluded. Our data on ROS production and apoptosis do not support the hypothesis that miR-127-3p is involved in regulating oxidative stress in HSC, and indeed miR-127-3p was not one of the miRNA for which a target within the PI3K-mTOR pathway was confirmed. 28 A mouse model with specific deletion of miR-127 was generated; 32 however, the effects on hematopoiesis have not been investigated.
MiR-127 is aberrantly expressed in the context of several solid tumors, potentially acting as either an oncogene (oncomiR) [33] [34] [35] or as a tumor suppressor. [36] [37] [38] [39] [40] [41] Within hematopoietic malignancies, miR-127 was found up-regulated, together with other miRNA included within the 14q32 domain, in the acute promyelocytic leukemia (APML) due to PML-RARa translocation. 42 It would be worth investigating whether miR-127 aberrant expression contributes to the differentiation block in APML myeloid progenitors. Although miR-127-3p overexpression did not lead to myelo-or lymphoproliferation, we cannot exclude that, in the presence of other genetic abnormalities, miR-127-3p may act as an oncomiR.
A number of miR-127-3p targets have been found in cancer cells, 21, 33, [35] [36] [37] [38] [39] 41 in other cell lines, 43, 44 or during development, 32 but they are either not expressed in hematopoietic progenitors, or their expression does not change in the HSC-to-MPP transition. Our search for predicted miR-127-3p targets within DE mRNA in the HSC-to-MPP transition and in Pbx1-deficient HSC revealed two potential targets, Gp1bb and Nek2 (Online Supplementary Table S3) . We confirmed by qRT-PCR their upregulation in the physiological HSC-to-MPP transition (data not shown); however, the increase in Gp1bb expression was extremely mild, whereas Nek2 seed-sequence is located within an alternatively spliced, non-coding portion of the transcript. It is, therefore, unlikely that Nek2 protein expression is directly regulated by miR-127-3p. Since miR-127-3p binding to its target mRNA might result in translation inhibition rather than mRNA degradation, a global proteomic approach would be required to gain insights on miR-127-3p functional targets mediating the observed phenotype, although protein analysis on rare primary HSC is technically challenging, especially in a model in which stem cells are reduced.
The physiological downregulation of miR-127-3p observed in the transition from HSC to MPP coincides with the loss of self-renewal ability that is known to occur during this differentiation step. Moreover, miR-127-3p is absent in HSC obtained from Pbx1-cKO mice, which display a profound self-renewal defect.present in Flk2 -MPP although at lower levels ( Figure 2B and C and Online Supplementary Table S1). However: 1) none of them was DE in HSC from our self-renewal defective mouse model; or 2) the downregulation was less than 3-fold. Among other miRNA whose function in the hematopoietic system has been previously established, miR-29a and miR-126 were shown to play a role in HSC self-renewal and to be differentially expressed in HSC compared to lineage-committed progenitors, but still highly expressed at the MPP stage, 11, 45 whereas miR-99 was recently found to be DE in the HSC-to-MPP transition. 20 Interestingly, these miRNA regulate HSC pool maintenance through different biological mechanisms. miR-126 restrains HSC cell cycle entry, while miR-99 and miR-29a limit HSC maturation, similar to miR-127. However, the accelerated differentiation displayed by miR-127DR cells was not associated to increased apoptosis or altered cell cycle. This might explain why the effect of miR-127DR was only observed with secondary transplants, since HSC depletion was likely due to a gradual exit of HSC from the self-renewing pool. Likewise, it is not surprising that the accelerated differentiation did not result in an increased differentiated progeny in vivo, since: a) differentiation was not associated with increased proliferation; and b) miR-127 is not normally expressed beyond the HSC stage, therefore an effect of miR-127DR in more mature cell population is not expected.
In conclusion, we identified miR-127 as novel player for preserving the HSC pool. Our discovery has potential implications for several translational aspects of experimental hematology, including hematopoietic malignancies, BM transplantation, and regenerative medicine.
